Evaluating AAV vectors for HHT gene therapy
Publication
, Conference
Liang, R; Press, K; Gonzalez, T; Asokan, A; Su, H
Published in: ANGIOGENESIS
2023
Duke Scholars
Published In
ANGIOGENESIS
EISSN
1573-7209
ISSN
0969-6970
Publication Date
2023
Volume
26
Issue
1
Start / End Page
S4 / S4
Related Subject Headings
- Oncology & Carcinogenesis
- 3101 Biochemistry and cell biology
- 1115 Pharmacology and Pharmaceutical Sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Liang, R., Press, K., Gonzalez, T., Asokan, A., & Su, H. (2023). Evaluating AAV vectors for HHT gene therapy. In ANGIOGENESIS (Vol. 26, pp. S4–S4).
Liang, R., K. Press, T. Gonzalez, A. Asokan, and H. Su. “Evaluating AAV vectors for HHT gene therapy.” In ANGIOGENESIS, 26:S4–S4, 2023.
Liang R, Press K, Gonzalez T, Asokan A, Su H. Evaluating AAV vectors for HHT gene therapy. In: ANGIOGENESIS. 2023. p. S4–S4.
Liang, R., et al. “Evaluating AAV vectors for HHT gene therapy.” ANGIOGENESIS, vol. 26, no. 1, 2023, pp. S4–S4.
Liang R, Press K, Gonzalez T, Asokan A, Su H. Evaluating AAV vectors for HHT gene therapy. ANGIOGENESIS. 2023. p. S4–S4.
Published In
ANGIOGENESIS
EISSN
1573-7209
ISSN
0969-6970
Publication Date
2023
Volume
26
Issue
1
Start / End Page
S4 / S4
Related Subject Headings
- Oncology & Carcinogenesis
- 3101 Biochemistry and cell biology
- 1115 Pharmacology and Pharmaceutical Sciences
- 1103 Clinical Sciences